drugset / Trial / NCT01773460
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
RandomizedParallel-groupTriple-blindTreatment
Summary
Everolimus will be given to patients with metastatic breast cancer who already has a progress taking Everolimus but with a change in the endocrine treatment.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | — |